Cheaper medicines and HECS cuts prioritised by Albanese

In Short:
– Albanese government plans to reduce PBS medicine prices to $25, saving users $200 million annually.
– Business Council proposes 18.5% R&D tax credit to boost economic productivity amidst upcoming tax reform discussions.

The Albanese government is set to introduce legislation aimed at lowering the price of PBS medicines to $25 when parliament resumes.

According to ABC News, this move, alongside the passage of HECS loan cuts, reflects their focus on cost-of-living measures.

The $25 price point, effective next year, is expected to reduce user costs by $200 million annually.

The previous $7.70 cost for pension and concession card holders will remain unchanged until 2030.

Both the government and opposition seem aligned on these healthcare reforms, with Labor also facing questions regarding future policies at an upcoming economic roundtable.

Policy Proposals

The Business Council has proposed enhanced tax credits for research and development, with a flat-rate incentive suggested at 18.5%.

The council advocates that increased R&D spending is pivotal for economic productivity and innovation.

Furthermore, discussions at the roundtable are expected to cover various tax reforms, including reconsideration of company tax to foster entrepreneurship. The Coalition, meanwhile, is anticipated to oppose new tax hikes while grappled with internal debates on climate targets.